Peptide therapy for over-40s: separating signal from TikTok hype

What did @bestself_over40 actually say?

The creator injected what she called "Samurlin" (almost certainly sermorelin, a growth hormone-releasing hormone analog) and described it as a peptide that tells your pituitary gland to "do its job better." She listed four benefits: deeper sleep, improved metabolism, lean muscle mass preservation, and workout recovery. She also mentioned cycling it for roughly three months with a planned break. The injection appears to be subcutaneous, roughly 10 units on the abdomen.

She's not claiming it replaces growth hormone directly. She's framing it as a stimulator of your own GH production. That framing matters, because it's the one thing she actually got mostly right in a video that otherwise breezes past a lot of nuance.

Does the science back this up?

Sermorelin does stimulate GH release, and there is legitimate clinical evidence supporting some of the benefits she describes. But the research is more conditional than she lets on, and most of it applies to people with documented GH deficiency, not healthy adults optimizing their biology.

Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) and was FDA-approved in 1997 for pediatric GH deficiency before being discontinued as a branded product. Its mechanism is real: it binds GHRH receptors in the pituitary and stimulates GH pulses. Walker et al. (1990, Journal of Clinical Endocrinology and Metabolism) demonstrated sermorelin increases GH secretion in adults with GH deficiency. Vittone et al. (1997, Metabolism) showed improvements in body composition and sleep architecture in GH-deficient adults treated with sermorelin over 6 months. The sleep benefit specifically links to GH's role in slow-wave sleep, which is the most defensible claim in this video. Metabolism and lean mass benefits are real in deficiency states but are far less established in eugonadal, GH-sufficient adults.

What did they get wrong (or right)?

The creator gets the mechanism right but oversells the certainty of the benefits for a general audience. Saying sermorelin will "improve your metabolism" and help with "lean muscle mass" as a blanket statement ignores that these outcomes are most consistently seen in people with confirmed low IGF-1 or GH deficiency, not in every woman over 40.

She also uses the word "cycle" correctly, which is more than most peptide content creators do. GH secretagogues can cause pituitary desensitization with continuous use, and taking planned breaks is a reasonable harm-reduction approach supported by the pharmacology, though no large randomized trial has defined an optimal cycle length. What she glosses over entirely: sermorelin obtained from compounding pharmacies is not FDA-approved in its current form, quality and sterility vary by compounder, and self-injection without baseline lab work (IGF-1, glucose, cortisol) is not a trivial decision. She also never mentions potential side effects: injection site reactions, water retention, joint discomfort, and transient insulin resistance are documented in the literature.

What should you actually know?

Sermorelin is one of the better-studied growth hormone secretagogues in clinical use, which makes it a reasonable subject for a telehealth conversation. But "reasonable to discuss with a provider" and "go ahead and inject based on a TikTok" are very different things. Here is what the evidence actually supports, and where the gaps are.

• GH secretion does decline with age, roughly 14% per decade after 30 (Iranmanesh et al., 1991, Journal of Clinical Endocrinology and Metabolism). Sermorelin addresses a real physiological change.
• Sleep quality improvements tied to sermorelin are the most consistently replicated benefit and are mechanistically plausible, since GH pulses peak during slow-wave sleep.
• Lean mass and metabolic benefits are documented in GH-deficient populations but should not be assumed for everyone. Without baseline IGF-1 testing, you do not know whether you are deficient.
• Compounded sermorelin is not the same as a previously approved branded formulation. Purity, potency, and sterility standards at compounding pharmacies are not uniformly regulated.
• Self-administration without medical oversight raises real safety questions, including the risk of hyperglycemia and the absence of monitoring for IGF-1 levels, which can climb too high with GH stimulation.

If you are interested in sermorelin, that conversation belongs with a licensed provider who can order baseline labs, not a comment thread.